Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

The nuclear receptor TR3 regulates mTORC1 signaling in lung cancer cells expressing wild-type p53

Oncogene volume 31, pages 3265–3276 (2012)Cite this article

A Corrigendum to this article was published on 05 July 2012

Abstract

The orphan nuclear receptor TR3 (NR41A and Nur77) is overexpressed in most lung cancer patients and is a negative prognostic factor for patient survival. The function of TR3 was investigated in non-small-cell lung cancer A549 and H460 cells, and knockdown of TR3 by RNA interference (siTR3) inhibited cancer cell growth and induced apoptosis. The prosurvival activity of TR3 was due, in part, to formation of a p300/TR3/ specificity protein 1 complex bound to GC-rich promoter regions of survivin and other Sp-regulated genes (mechanism 1). However, in p53 wild-type A549 and H460 cells, siTR3 inhibited the mTORC1 pathway, and this was due to activation of p53 and induction of the p53-responsive gene sestrin 2, which subsequently activated the mTORC1 inhibitor AMP-activated protein kinase α (AMPKα) (mechanism 2). This demonstrates that the pro-oncogenic activity of TR3 in lung cancer cells was due to inhibition of p53 and activation of mTORC1. 1,1-Bis(3’-indolyl)-1-(p-hydroxyphenyl)methane (DIM-C-pPhOH) is a recently discovered inhibitor of TR3, which mimics the effects of siTR3. DIM-C-pPhOH inhibited growth and induced apoptosis in lung cancer cells and lung tumors in murine orthotopic and metastatic models, and this was accompanied by decreased expression of survivin and inhibition of mTORC1 signaling, demonstrating that inactivators of TR3 represent a novel class of mTORC1 inhibitors.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  • Azoitei N, Pusapati GV, Kleger A, Moller P, Kufer R, Genze F et al. (2010). Protein kinase D2 is a crucial regulator of tumour cell-endothelial cell communication in gastrointestinal tumours. Gut 59: 1316–1330.

    Article  CAS  Google Scholar 

  • Bjornsti MA, Houghton PJ . (2004). The TOR pathway: a target for cancer therapy. Nat Rev Cancer 4: 335–348.

    Article  CAS  Google Scholar 

  • Bras A, Albar JP, Leonardo E, de Buitrago GG, Martinez A . (2000). Ceramide-induced cell death is independent of the Fas/Fas ligand pathway and is prevented by Nur77 overexpression in A20 B cells. Cell Death Differ 7: 262–271.

    Article  CAS  Google Scholar 

  • Budanov AV, Karin M . (2008). p53 target genes sestrin1 and sestrin2 connect genotoxic stress and mTORC1 signaling. Cell 134: 451–460.

    Article  CAS  Google Scholar 

  • Chen L, Hu L, Chan TH, Tsao GS, Xie D, Huo KK et al. (2009). Chromodomain helicase/adenosine triphosphatase DNA binding protein 1-like (CHD1l) gene suppresses the nucleus-to-mitochondria translocation of nur77 to sustain hepatocellular carcinoma cell survival. Hepatology 50: 122–129.

    Article  CAS  Google Scholar 

  • Chen L, Yuan YF, Li Y, Chan TH, Zheng BJ, Huang J et al. (2010). Clinical significance of CHD1L in hepatocellular carcinoma and therapeutic potentials of virus-mediated CHD1L depletion. Gut 60: 534–543.

    Article  Google Scholar 

  • Chintharlapalli S, Burghardt R, Papineni S, Ramaiah S, Yoon K, Safe S . (2005). Activation of Nur77 by selected 1,1-Bis(3’-indolyl)-1-(p-substituted phenyl)methanes induces apoptosis through nuclear pathways. J Biol Chem 280: 24903–24914.

    Article  CAS  Google Scholar 

  • Cho SD, Lee SO, Chintharlapalli S, Abdelrahim M, Khan S, Yoon K et al. (2010). Activation of nerve growth factor-induced Bα by methylene-substituted diindolylmethanes in bladder cancer cells induces apoptosis and inhibits tumor growth. Mol Pharmacol 77: 396–404.

    Article  CAS  Google Scholar 

  • Cho SD, Yoon K, Chintharlapalli S, Abdelrahim M, Pei P, Hamilton S et al. (2007). Nur77 agonists induce proapoptotic genes and responses in colon cancer cells through nuclear receptor-dependent and independent pathways. Cancer Res 67: 674–683.

    Article  CAS  Google Scholar 

  • Gronemeyer H, Gustafsson JA, Laudet V . (2004). Principles for modulation of the nuclear receptor superfamily. Nat Rev Drug Discov 3: 950–964.

    Article  CAS  Google Scholar 

  • Guertin DA, Sabatini DM . (2007). Defining the role of mTORC1 in cancer. Cancer Cell 12: 9–22.

    Article  CAS  Google Scholar 

  • Hay N, Sonenberg N . (2004). Upstream and downstream of mTORC1. Genes Dev 18: 1926–1945.

    Article  CAS  Google Scholar 

  • Ke N, Claassen G, Yu DH, Albers A, Fan W, Tan P et al. (2004). Nuclear hormone receptor NR4A2 is involved in cell transformation and apoptosis. Cancer Res 64: 8208–8212.

    Article  CAS  Google Scholar 

  • Kolluri SK, Bruey-Sedano N, Cao X, Lin B, Lin F, Han YH et al. (2003). Mitogenic effect of orphan receptor TR3 and its regulation by MEKK1 in lung cancer cells. Mol Cell Biol 23: 8651–8667.

    Article  CAS  Google Scholar 

  • Kolluri SK, Zhu X, Zhou X, Lin B, Chen Y, Sun K et al. (2008). A short Nur77-derived peptide converts Bcl-2 from a protector to a killer. Cancer Cell 14: 285–298.

    Article  CAS  Google Scholar 

  • Lee JH, Budanov AV, Park EJ, Birse R, Kim TE, Perkins GA et al. (2010a). Sestrin as a feedback inhibitor of TOR that prevents age-related pathologies. Science 327: 1223–1228.

    Article  CAS  Google Scholar 

  • Lee SO, Abdelrahim M, Yoon K, Chintharlapalli S, Papineni S, Kim K et al. (2010b). Inactivation of the orphan nuclear receptor TR3/Nur77 inhibits pancreatic cancer cell and tumor growth. Cancer Res 70: 6824–6836.

    Article  CAS  Google Scholar 

  • Lee SO, Chintharlapalli S, Liu S, Papineni S, Cho SD, Yoon K et al. (2009). p21 Expression is induced by activation of nuclear nerve growth factor-induced Bα (NGFI-Bα, Nur77) in pancreatic cancer cells. Mol Cancer Res 7: 1169–1178.

    Article  CAS  Google Scholar 

  • Li H, Kolluri SK, Gu J, Dawson MI, Cao X, Hobbs PD et al. (2000). Cytochrome c release and apoptosis induced by mitochondrial targeting of nuclear orphan receptor TR3. Science 289: 1159–1164.

    Article  CAS  Google Scholar 

  • Li QX, Ke N, Sundaram R, Wong-Staal F . (2006). NR4A1, 2, 3--an orphan nuclear hormone receptor family involved in cell apoptosis and carcinogenesis. Histol Histopathol 21: 533–540.

    CAS  PubMed  Google Scholar 

  • Lin B, Kolluri SK, Lin F, Liu W, Han YH, Cao X et al. (2004). Conversion of Bcl-2 from protector to killer by interaction with nuclear orphan receptor Nur77/TR3. Cell 116: 527–540.

    Article  CAS  Google Scholar 

  • Liu JJ, Zeng HN, Zhang LR, Zhan YY, Chen Y, Wang Y et al. (2010). A unique pharmacophore for activation of the nuclear orphan receptor Nur77 in vivo and in vitro. Cancer Res 70: 3628–3637.

    Article  CAS  Google Scholar 

  • Maruyama K, Tsukada T, Bandoh S, Sasaki K, Ohkura N, Yamaguchi K . (1995). Expression of NOR-1 and its closely related members of the steroid/thyroid hormone receptor superfamily in human neuroblastoma cell lines. Cancer Lett 96: 117–122.

    Article  CAS  Google Scholar 

  • Maxwell MA, Muscat GE . (2006). The NR4A subgroup: immediate early response genes with pleiotropic physiological roles. Nucl Recept Signal 4: e002.

    Article  Google Scholar 

  • McKenna NJ, Cooney AJ, DeMayo FJ, Downes M, Glass CK, Lanz RB et al. (2009). Minireview: evolution of NURSA, the nuclear receptor signaling atlas. Mol Endocrinol 23: 740–746.

    Article  CAS  Google Scholar 

  • Milbrandt J . (1988). Nerve growth factor induces a gene homologous to the glucocorticoid receptor gene. Neuron 1: 183–188.

    Article  CAS  Google Scholar 

  • Pearen MA, Muscat GE . (2010). Minireview: nuclear hormone receptor 4A signaling: implications for metabolic disease. Mol Endocrinol 24: 1891–1903.

    Article  CAS  Google Scholar 

  • Shaw RJ, Cantley LC . (2006). Ras, PI(3)K and mTORC1 signalling controls tumour cell growth. Nature 441: 424–430.

    Article  CAS  Google Scholar 

  • She QB, Halilovic E, Ye Q, Zhen W, Shirasawa S, Sasazuki T et al. (2010). 4E-BP1 is a key effector of the oncogenic activation of the AKT and ERK signaling pathways that integrates their function in tumors. Cancer Cell 18: 39–51.

    Article  CAS  Google Scholar 

  • Wu H, Lin Y, Li W, Sun Z, Gao W, Zhang H et al. (2010). Regulation of Nur77 expression by {beta}-catenin and its mitogenic effect in colon cancer cells. FASEB J 25: 192–205.

    Article  Google Scholar 

  • Yang Q, Guan KL . (2007). Expanding mTORC1 signaling. Cell Res 17: 666–681.

    Article  CAS  Google Scholar 

  • Zeng H, Qin L, Zhao D, Tan X, Manseau EJ, Van HM et al. (2006). Orphan nuclear receptor TR3/Nur77 regulates VEGF-A-induced angiogenesis through its transcriptional activity. J Exp Med 203: 719–729.

    Article  CAS  Google Scholar 

  • Zhan Y, Du X, Chen H, Liu J, Zhao B, Huang D et al. (2008). Cytosporone B is an agonist for nuclear orphan receptor Nur77. Nat Chem Biol 4: 548–556.

    Article  CAS  Google Scholar 

  • Zhang XK . (2007). Targeting Nur77 translocation. Expert Opin Ther Targets 11: 69–79.

    Article  CAS  Google Scholar 

  • Zhao BX, Chen HZ, Lei NZ, Li GD, Zhao WX, Zhan YY et al. (2006). p53 mediates the negative regulation of MDM2 by orphan receptor TR3. EMBO J 25: 5703–5715.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by National Institutes of Health (R01-CA124998) and the Texas A&M AgriLife.

Author information

Authors and Affiliations

  1. Institute of Bioscience and Technology, Texas A&M Health Science Center, Houston, TX, USA

    S-O Lee, U-H Jin, K Kim & S Safe

  2. Department of Pharmaceutics, College of Pharmacy and Pharmaceutical Sciences, Florida A&M University, Tallahassee, FL, USA

    T Andey & M Sachdeva

  3. Department of Veterinary Physiology and Pharmacology, Texas A&M University, College Station, TX, USA

    S Safe

Authors
  1. S-O Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. T Andey
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. U-H Jin
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. K Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M Sachdeva
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. S Safe
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S Safe.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies the paper on the Oncogene website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lee, SO., Andey, T., Jin, UH. et al. The nuclear receptor TR3 regulates mTORC1 signaling in lung cancer cells expressing wild-type p53. Oncogene 31, 3265–3276 (2012). https://doi.org/10.1038/onc.2011.504

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/onc.2011.504

Keywords

This article is cited by

Search

Advanced search

Quick links